HRs for the association between A1C levels and mortality in a New Zealand population-based sample by cause of death
| Site (ICD-9) | n | A1C levels
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| <4.0%
|
4.0 to <5.0%
|
5.0 to <6.0%
|
6.0 to <7.0%
|
≥7.0%
|
Prior diabetes diagnosis
|
|||||||||||||||||||
| n | HR (95% CI)* | n | HR (95% CI)* | n | HR (95% CI)* | n | HR (95% CI)* | n | HR (95% CI)* | n | HR (95% CI)* | |||||||||||||
| All deaths | 815 | 3 | 2.90 (0.91–9.19) | 82 | 1.0† | 449 | 1.33 (1.05–1.70) | 129 | 2.12 (1.58–2.85) | 87 | 2.36 (1.72–3.25) | 65 | 5.19 (3.67–7.35) | |||||||||||
| All cancers (140–239) | 262 | 0 | ‡ | 26 | 1.0† | 154 | 1.10 (0.72–1.68) | 44 | 1.50 (0.90–2.48) | 23 | 1.29 (0.72–2.30) | 15 | 2.35 (1.22–4.53) | |||||||||||
| Endocrine, nutritional & metabolic, and immunity disorders (240–279) | 47 | 0 | ‡ | 0 | ‡ | 6 | 1.0† | 2 | 1.79 (0.35–9.18) | 19 | 27.17 (10.20–72.39) | 20 | 90.36 (33.42–244.33) | |||||||||||
| Diseases of circulatory system (390–459) | 280 | 1 | 3.95 (0.53–29.51) | 20 | 1.0† | 151 | 1.43 (0.89–2.30) | 54 | 2.46 (1.44–4.19) | 32 | 2.44 (1.37–4.35) | 22 | 4.75 (2.53–8.92) | |||||||||||
| Ischemic heart disease (410–414) | 166 | 1 | 6.26 (0.81–48.13) | 13 | 1.0† | 91 | 1.27 (0.71–2.30) | 26 | 1.75 (0.88–3.49) | 23 | 2.55 (1.26–5.16) | 12 | 3.89 (1.72–8.77) | |||||||||||
| Other and unknown causes | 226 | 2 | 4.53 (1.09–18.85) | 36 | 1.0† | 138 | 1.41 (0.96–2.06) | 29 | 2.52 (1.47–4.31) | 13 | 1.86 (0.95–3.65) | 8 | 3.88 (1.72–8.74) | |||||||||||